Article

Materialise reported €70.2 million in revenue for Q4 2025, up 6.8% from the previous year, with the medical division driving a 16.3% increase. Annual turnover was €267.6 million, nearly unchanged from 2024, attributed to weaker manufacturing demand and currency impacts.

The gross margin improved to 58.1% in Q4, with adjusted EBIT at €4.0 million, contrasting with a loss in the prior year. Net profit for 2025 was €7.7 million, lower than 2024. The company emphasized its solid financial standing with €134 million in cash, continued R&D investments, and a strategic shift in manufacturing aimed at aerospace and defense markets.